文献速递妇科产科

超声诊断非输卵管异位妊娠后管理方案的比较:一项回顾性队列研究

Comparison of management regimens following ultrasound diagnosis of nontubal ectopic pregnancies: a retrospective cohort study.
PubMed 文献 · BJOG · 2017-06-19

该回顾性队列研究纳入澳大利亚墨尔本一家三级医院的100例非输卵管妊娠(腹部1例、剖宫产瘢痕32例、宫颈14例、宫角-间质41例、卵巢12例),评估药物、手术、联合或期待等初始管理方案的成功率与计划外干预频率。所有方案总成功率为82%,无死亡且并发症少;全身甲氨蝶呤或超声引导囊内注射的成功率为88%,初始手术成功率为57%。作者认为微创方法安全有效,超声引导囊内注射和腹腔镜下保留生殖器官的异位妊娠去除术应作为微创初始管理工具。

要点

  • 100例非输卵管妊娠中,所有初始管理方案总成功率为82%,无死亡发生。
  • 全身甲氨蝶呤或超声引导囊内注射的初始成功率均为88%,初始手术成功率为57%。
  • 超声引导注射联合全身甲氨蝶呤成功率94%,单用全身甲氨蝶呤成功率81%。

核心结论

  • 微创方法对希望保留生育力的女性是安全有效的治疗。
  • 作者建议将超声引导囊内注射和旨在保留生殖器官的腹腔镜异位妊娠去除术,与全身甲氨蝶呤一起列为微创初始管理工具。

研究设计与样本

  • 回顾性队列研究,在澳大利亚墨尔本一家三级医院开展。
  • 共纳入100例非输卵管妊娠:腹部1例、剖宫产瘢痕32例、宫颈14例、宫角-间质41例、卵巢12例。
  • 按异位妊娠部位分类,初始管理分为药物、手术、联合或期待;识别微创方法(超声引导囊内注射或选择性手术技术)的使用。
  • 初始管理成功定义为无需进一步的计划外干预。

主要发现

  • 所有管理方案的总成功率为82%,并发症少且无死亡发生。
  • 初始管理为全身甲氨蝶呤或超声引导囊内注射时成功率为88%。
  • 初始手术管理的成功率为57%。
  • 初始管理为超声引导注射或联合全身甲氨蝶呤时成功率为94%;单用全身甲氨蝶呤时成功率为81%。
  • 采用微创手术方法的女性中75%避免了更大范围的手术,但需要更长的随访和额外干预。

关键数值与推荐

  • 初始管理成功定义为无需进一步的计划外干预。

临床怎么用

  • 作者认为微创方法对希望保留生育力的女性是安全有效的治疗。
  • 作者建议将超声引导囊内注射和旨在保留生殖器官的腹腔镜异位妊娠去除术,与全身甲氨蝶呤一起列为微创初始管理工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review management options for nontubal ectopic pregnancies. DESIGN: Retrospective cohort study. SETTING: Tertiary hospital in Melbourne, Australia. POPULATION: A total of 100 nontubal pregnancies: 1 abdominal, 32 caesarean scar, 14 cervical, 41 cornual-interstitial, 12 ovarian. METHODS: Cases were classified according to ectopic site. Management categories were medical, surgical, combination or expectant. Use of minimally invasive approaches (ultrasound-guided intra-sac injections or selective surgical techniques) was identified. Primary management was considered to be successful if no further unplanned interventions were required. MAIN OUTCOME MEASURES: Success of primary management and frequency of unplanned interventions. RESULTS: A high rate of success (82%) was demonstrated for all management regimens, with minimal morbidity and no deaths occurring. A high success rate was shown when the primary management regimen was systemic methotrexate or ultrasound-guided intra-sac injection (88%). The success rate for primary surgical management was 57%. High success rates were reported for both primary management with ultrasound-guided injections or in combination with systemic methotrexate (94%) and for primary management with systemic methotrexate alone (81%). Seventy-five per cent of women managed with minimally invasive surgical approaches avoided the need for more extensive surgery, but required longer follow up and additional interventions. CONCLUSION: Minimally invasive approaches were found to be safe and effective treatment for women desiring to conserve fertility. Ultrasound-guided intra-sac injection and laparoscopic ectopic removal procedures aimed at preserving reproductive organs should be included as minimally invasive primary management tools in addition to the well-recognised option of systemic methotrexate. TWEETABLE ABSTRACT: Nontubal ectopics: minimally invasive procedures a safe alternative to surgery in selected cases.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Ramkrishna J, Kan GR, Reidy KL, et al. Comparison of management regimens following ultrasound diagnosis of nontubal ectopic pregnancies: a retrospective cohort study. BJOG. 2017. PMID: 28626980. doi:10.1111/1471-0528.14752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。